Agrawal, Renuka MD

NeoGenomics is a leader in oncology diagnostics, offering an extensive array of over 500 tests that encompass all major testing modalities, including single gene molecular testing, immunohistochemistry, flow cytometry, and next-generation sequencing. With a commitment to precision oncology, the company provides personalized diagnostic data and therapeutic guidance to support oncologists in delivering tailored patient care. In addition to its diagnostic capabilities, NeoGenomics collaborates with biopharmaceutical partners to expedite drug development and clinical trials, all while maintaining access to a broad dataset that reflects the diversity of the U.S. population. The company's Patient Support team is dedicated to assisting individuals through complex aspects of cancer testing, insurance, and billing. Generated from the website

NeoGenomics Laboratories is a leader in oncology diagnostics, providing an extensive range of over 500 tests that encompass various testing modalities, including molecular testing, immunohistochemistry, and next-generation sequencing. Their commitment to precision oncology supports oncologists by delivering personalized patient care through advanced diagnostic solutions tailored to the evolving cancer landscape. With a vast dataset derived from over 2 million patient profiles, NeoGenomics plays an essential role in cancer therapy innovation, aiding biopharma partners in drug development and clinical trials. Their Patient Support team is dedicated to guiding individuals through the complexities of cancer diagnosis, testing, and treatment, ensuring access to vital resources and information during challenging times. Generated from the website

NeoGenomics is a leader in oncology diagnostics, providing an extensive range of over 500 tests that support personalized cancer care. Their advanced testing capabilities encompass various modalities, including molecular testing, immunohistochemistry, and next-generation sequencing, ensuring precision in diagnosing solid tumors and hematologic cancers. Committed to advancing cancer therapy, NeoGenomics collaborates with biopharmaceutical partners to accelerate drug development and clinical trials. Their comprehensive oncology data solutions offer unmatched insights that aid in informed clinical decisions, ultimately enhancing patient outcomes during treatment. Generated from the website